Bradley Pharmaceuticals, Inc.

Pharma firm focused on acquiring non-strategic brands announces extension to file form 10-K

Published in Physician Law Weekly, February 1st, 2006

Bradley Pharmaceuticals, Inc., (BDY) announced that the New York Stock Exchange has granted the company an extension through January 31, 2006 to file its annual report on Form 10-K for the year ended December 31, 2004.

This extension is subject to review by the NYSE on an ongoing basis. Should the company be unable to meet this deadline, it may request up to an additional 2 months to file its 2004 Form 10-K, which request will be subject to formal re-evaluation by the NYSE.

On December 19, 2005, the company announced that it anticipated filing its 2004 Form 10-K on or about January 31, 2006.

Bradley Pharmaceuticals acquires...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly

Source: Physician Law Weekly (2006-02-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry